Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals

J Infect Dis. 2007 Apr 1;195(7):960-4. doi: 10.1086/511988. Epub 2007 Feb 16.

Abstract

Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), a human cytidine deaminase, is a potent inhibitor of HIV replication. To explore a possible role of this protein in modulating in vivo susceptibility to HIV infection, we analyzed APOBEC3G expression in HIV-exposed seronegative individuals, HIV-seropositive patients, and healthy control subjects. The results showed that the expression of APOBEC3G is significantly increased in peripheral blood mononuclear cells (PBMCs)--mainly CD14(+) cells--and in cervical tissues of HIV-exposed seronegative individuals. Higher APOBEC3G expression correlated with a reduced susceptibility of PBMCs to in vitro infection with the HIV-1(Ba-L) R5 strain. APOBEC3G could be important in modulating in vivo susceptibility to sexually transmitted HIV infection.

MeSH terms

  • APOBEC-1 Deaminase
  • Case-Control Studies
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / metabolism*
  • Female
  • HIV Infections / blood
  • HIV Infections / virology*
  • HIV Seropositivity
  • HIV-1 / pathogenicity
  • HIV-1 / physiology*
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • RNA Editing
  • RNA, Messenger / analysis
  • Virus Replication / physiology

Substances

  • RNA, Messenger
  • APOBEC-1 Deaminase
  • APOBEC1 protein, human
  • Cytidine Deaminase